Bisoprolol Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg, 10 mg
Reference Brands: Zebeta, Monocor(US); Concor(EU)
Category:
Heart Disorder
Bisoprolol is a selective beta-1 blocker that reduces heart rate, blood pressure, and myocardial oxygen demand by blocking adrenaline effects on the heart. It effectively manages hypertension, angina, and heart failure. Benefits include improved cardiovascular stability, symptom control, decreased risk of heart attacks, and enhanced overall heart health.
Bisoprolol tablets is available in Tablet
and strengths such as 2.5 mg, 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bisoprolol tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bisoprolol tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bisoprolol tablets, marketed as Zebeta and Concor, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and heart failure. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The US FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Regional compliance supports prompt approval, safe use, and broader availability, helping improve cardiovascular outcomes and quality of life worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing